Cellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease

References

• Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17: 484–99
   PubMed Web of Science ®Google Scholar
• Idee JM, Port M, Raynal I, et al. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 2006; 20: 563–76
   PubMed Web of Science ®Google Scholar
• Limanond P, Raman SS, Sayre J, Lu DS. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners. J Magn Reson Imaging 2004; 20: 640–7
   Google Scholar
• Frank JA, Anderson SA, Kalsih H, et al. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 2004; 6: 621–5
   PubMed Web of Science ®Google Scholar
• Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol Imaging 2005; 4: 143–64
   PubMed Web of Science ®Google Scholar
• Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006; 34: 23–38
   PubMed Web of Science ®Google Scholar
• Bowen CV, Zhang X, Saab G, et al. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002; 48: 52–61
   PubMed Web of Science ®Google Scholar
• Politi LS. MR-based imaging of neural stem cells. Neuroradiology 2007; 49: 523–34
   PubMedGoogle Scholar
• Daldrup-Link HE, Rudelius M, Piontek G, et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005; 234: 197–205
   PubMed Web of Science ®Google Scholar
• Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003; 107: 2290–3
   PubMed Web of Science ®Google Scholar
• Garot J, Unterseeh T, Teiger E, et al. Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. J Am Coll Cardiol 2003; 41: 1841–6
   PubMed Web of Science ®Google Scholar
• Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed 2006; 19: 636–54
   PubMed Web of Science ®Google Scholar
• Adame IM, de Koning PJ, Lelieveldt BP, et al. An integrated automated analysis method for quantifying vessel stenosis and plaque burden from carotid MRI images: combined postprocessing of MRA and vessel wall MR. Stroke 2006; 37: 2162–4
   Google Scholar
• Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA 2007; 104: 961–6
   PubMed Web of Science ®Google Scholar
• Rogers WJ, Basu P. Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging. Atherosclerosis 2005; 178: 67–73
   PubMed Web of Science ®Google Scholar
• Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995; 13: 661–74
   PubMed Web of Science ®Google Scholar
• Tang TY, Howarth SP, Li ZY, et al. Correlation of carotid atheromatous plaque inflammation with biomechanical stress: utility of USPIO enhanced MR imaging and finite element analysis. Atherosclerosis 2008; 196: 879–87
   PubMed Web of Science ®Google Scholar
• Küstermann E, Roell W, Breitbach M, et al. Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation. NMR Biomed 2005; 18: 362–70
   Google Scholar
• Arbab AS, Bashaw LA, Miller BR, et al. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003; 76: 1123–30
   PubMed Web of Science ®Google Scholar
• Ahrens ET, Feili-Hariri M, Xu H, et al. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 2003; 49: 1006–13
   PubMed Web of Science ®Google Scholar
• Song M, Moon WK, Kim Y, et al. Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO. Korean J Radiol 2007; 8: 365–71
   PubMed Web of Science ®Google Scholar
• Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003; 108: 1009–14
   PubMed Web of Science ®Google Scholar
• Smirnov P, Lavergne E, Gazeau F, et al. In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy. Magn Reson Med 2006; 56: 498–508
   Google Scholar
• Cahill KS, Gaidosh G, Huard J, et al. Noninvasive monitoring and tracking of muscle stem cell transplants. Transplantation 2004; 78: 1626–33
   PubMed Web of Science ®Google Scholar
• Sun R, Dittrich J, Le-Huu M, et al. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol 2005; 40: 504–13
   PubMed Web of Science ®Google Scholar
• Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomed 2007; 2: 23–39
   PubMed Web of Science ®Google Scholar
• Kooi ME, Cappendijk VC, Cleutjens KB, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation; ;107 2003; 20: 2453–8
   Google Scholar
• Trivedi RA, Mallawarachi C, U-King-Im J, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006; 26: 1601–6
   PubMed Web of Science ®Google Scholar
• Matuszewski L, Tombach B, Heindel W, Bremer C. Molecular and parametric imaging with iron oxides. Radiologe 2007; 47: 34–42
   Google Scholar
• Bulte JW, Douglas T, Witwer B, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001; 19: 1141–7
   PubMed Web of Science ®Google Scholar
• Cunningham CH, Arai T, Yang PC, et al. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005; 53: 999–1005
   PubMed Web of Science ®Google Scholar
• Mani V, Briley-Saebo KC, Itskovich VV, et al. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med 2006; 55: 125–6
   Google Scholar
• Mauriello A, Sangiorgi G, Fratoni S, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005; 17;45: 1585–93
   Google Scholar
• Landmesser U, Drexler H. Chronic heart failure: an overview of conventional treatment versus novel approaches. Nat Clin Pract Cardiovasc Med 2005; 2: 628–68
   Google Scholar
• Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006; 37: 1923–32
   PubMed Web of Science ®Google Scholar
• Antohe F. Endothelial cells and macrophages, partners in atherosclerotic plaque progression. Arch Physiol Biochem 2006; 112: 245–53
   PubMedGoogle Scholar
• Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054–61
   PubMed Web of Science ®Google Scholar
• Lim WS, Timmins JM, Seimon TA, et al. Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation 2008; 117: 940–51
   PubMed Web of Science ®Google Scholar
• Briley-Saebo KC, Mulder WJ, Mani V, et al. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging 2007; 26: 460–79
   PubMed Web of Science ®Google Scholar
• Schmitz SA, Taupitz M, Wagner S, et al. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 2001; 14: 355–61
   PubMed Web of Science ®Google Scholar
• Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001; 103: 415–22
   PubMed Web of Science ®Google Scholar
• Herborn CU, Vogt FM, Lauenstein TC, et al. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide. J Magn Reson Imaging 2006; 24: 388–93
   PubMed Web of Science ®Google Scholar
• Schmitz SA, Coupland SE, Gust R, et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol 2000; 35: 460–71
   PubMed Web of Science ®Google Scholar
• Yancy AD, Olzinski AR, Hu TC, et al. Differential uptake of Ferumoxtran-10 and Ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. J Magn Reson Imaging 2005; 21: 432–42
   PubMed Web of Science ®Google Scholar
• Priest AN, Ittrich H, Jahntz C, et al. Investigation of atherosclerotic plaques with MRI at 3T using ultrasmall superparamagnetic particles of iron oxide. MRI 2006; 24: 1287–93
   Google Scholar
• Hyafil F, Laissy J-P, Mazighi M, et al. Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vasc Biol 2006; 26: 176–81
   Google Scholar
• Morris JB, Olzinski AR, Bernard RE, et al. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol 2008; 28: 265–71
   PubMed Web of Science ®Google Scholar
• Howarth S, Li ZY, Trivedi RA, et al. Correlation of macrophage location and plaque stress distribution using USPIO-enhanced MRI in a patient with symptomatic severe carotid stenosis: a new insight into risk stratification. Br J Neurosurg 2007; 21: 396–8
   PubMed Web of Science ®Google Scholar
• Tang T, Howarth SP, Miller SR, et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006; 37: 2266–70
   PubMed Web of Science ®Google Scholar
• Allan R, Kass M, Glover C, Haddad H. Cellular transplantation: future therapeutic options. Curr Opin Cardiol 2007; 22: 104–10
   PubMedGoogle Scholar
• Rogers WJ, Meyer CH, Kramer CM. Technology insight: in vivo cell tracking by use of MRI. Nat Clin Pract Cardiovasc Med 2006; 3: 554–62
   PubMedGoogle Scholar
• Bulte JWM, Ma LD, Magin RL, et al. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med 1993; 29: 32–7
   PubMed Web of Science ®Google Scholar
• Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480–7
   PubMed Web of Science ®Google Scholar
• Arbab AS, Yocum GT, Wilson LB, et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004; 3: 24–32
   PubMedGoogle Scholar
• Arbab AS, Yocum GT, Kalish H, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004; 104: 1217–23
   PubMed Web of Science ®Google Scholar
• Zhang Z, van den Bos EJ, Wielopolski PA, et al. In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner. MAGMA 2005; 18: 175–85
   PubMedGoogle Scholar
• Zhang Z, van den Bos EJ, Wielopolski PA, et al. High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner. MAGMA 2004; 17: 201–9
   Google Scholar
• Kalish H, Arbab AS, Miller BR, et al. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med 2003; 50: 275–82
   PubMed Web of Science ®Google Scholar
• Koch AM, Reynolds F, Kircher MF, et al. Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug Chem 2003; 14: 1115–21
   PubMed Web of Science ®Google Scholar
• Zhao M, Kircher MF, Josephson L, Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem 2002; 13: 840–4
   PubMed Web of Science ®Google Scholar
• Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18: 410–14
   PubMed Web of Science ®Google Scholar
• Walczak P, Kedziorek DA, Gilad AA, et al. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005; 54: 769–74
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Zhang S, Kundu P, et al. In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. Magn Reson Med 2007; 57: 1173–9
   Google Scholar
• Wu YL, Ye Q, Foley LM, et al. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc Natl Acad Sci USA 2006; 103: 1852–7
   PubMedGoogle Scholar
• Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005; 102: 11474–9
   PubMed Web of Science ®Google Scholar
• van den Bos EJ, Baks T, Moelker AD, et al. Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking?. Eur Heart J 2006; 27: 1620–6
   Google Scholar
• Stuber M, Gilson WD, Schär M, et al. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med 2007; 58: 1072–7
   PubMed Web of Science ®Google Scholar
• Himes N, Min JY, Lee R, et al. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 2004; 52: 1214–19
   PubMed Web of Science ®Google Scholar
• Ruhparwar A, Ghodsizad A, Niehaus M, et al. Clinically applicable 7-Tesla magnetic resonance visualization of transplanted human adult stem cells labeled with CliniMACS nanoparticles. Thorac Cardiovasc Surg 2006; 54: 447–51
   Google Scholar
• Baklanov DV, Demuinck ED, Thompson CA, et al. Novel double contrast MRI technique for intramyocardial detection of percutaneously transplanted autologous cells. Magn Reson Med 2004; 52: 1438–42
   PubMed Web of Science ®Google Scholar
• Küstermann E, Roell W, Breitbach M, et al. Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation. NMR Biomed 2005; 18: 362–370
   Google Scholar
• Leor J, Rozen L, Zuloff-Shani A, et al. Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation 2006; 114: I94–100
   PubMed Web of Science ®Google Scholar